explore -WSS

explore

author：explore 2025-09-14 11:51:46 - browse：51

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

hotspot

WSS

EPA limits use of carcinogenic gas for sterilizing medical devices

Readout LOUD podcast: Live from the 2023 STAT Summit

Medicare coverage of Wegovy, once blocked, now looks possible

UCLA team creates talking throat patch for voice disorders

As AI in medicine takes off, can 'human in the loop' prevent harm?

First U.S. drug developed to treat liver disease MASH is approved

knowledge

explore

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Apple is now the first public company to be valued at $3 trillion

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

RaDonda Vaught links Vanderbilt hospital issues to patient death

Jerome Adams on the need for new antivirals for Covid

Roche drug slashes death risk in early

What does generative AI mean for health care? We asked experts

First U.S. drug developed to treat liver disease MASH is approved

leisure time

As AI in medicine takes off, can 'human in the loop' prevent harm?

Why scientists need input from humanists on sensitive research

As AI in medicine takes off, can 'human in the loop' prevent harm?

Male and female sex labels in research insufficient, scientists say

FDA clears Verve to begin U.S. study of gene

J&J lung cancer data amount to new salvo against AstraZeneca

hotspot

hotspot

hotspot

hotspot